BioProducts presented the new assays for pharmacogenetics at the tewenties anniversary of ISMD. The new SLCO1B1 and VKORC1 real-time assays are developed to optimized the therapeutic treatment by mutation screening. Additional the new service for NGS consulting has turned out to be an innovative support for the visitors at our booth.
BioProducts enjoyed to be a part of the ISMD community and congratulates the organiser for this great event.
